That involved sponsored courses that were offered in 2021 and 2022 via the LinkedIn social media platform, focusing on the use of Novo Nordisk's GLP-1 agonist Saxenda (liraglutide) and deemed to ...

Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

Danish drugmaker Novo Nordisk has bought global rights to China-based United Laboratories International's so-called "triple-G" weight-loss drug candidate in a deal worth up to $2 billion.